The NovaSeq X system features Illumina's cutting-edge XLEAP-SBS chemistry, offering unmatched throughput, accuracy, and sustainability
Vimta Labs has reported total income of Rs. 96.08 crores during the period ended March 31, 2025
The foray into this new segment will help Vimta to enter into the growing CDMO business of biologics and peptides
The company has reported total income of Rs. 628.4 crores during the period ended March 31, 2025
The 27 greenfield labs across the country ensure timely and accurate reporting
The company delivered revenues of Rs. 5,554 crore, representing 10% growth in FY25
Aarti Pharmalabs becomes 6th Indian Pharma/CDMO to earn SBTi approval for all 3 Scopes since 2022 demerger
More than 40 types of Amyloid proteins are discovered till date
Pregabalin Gel 8% is a novel topical solution for diabetic neuropathic pain
Laurus Labs has reported total income of Rs. 1,424.47 crores during the period ended December 31, 2024
Subscribe To Our Newsletter & Stay Updated
